Attending rounds: Microangiopathic hemolytic anemia with renal insufficiency

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 2, 2012, Pages 342-347

  Clark, William F ^a   Hildebrand, Ainslie ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; D DIMER; DIPHENHYDRAMINE; DISINTEGRIN; ECULIZUMAB; LACTATE DEHYDROGENASE; METALLOPROTEINASE; METHYLPREDNISOLONE; RITUXIMAB; THROMBOSPONDIN 1; TROPONIN I; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DISSEMINATED INTRAVASCULAR CLOTTING; FAMILY HISTORY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; MEDICAL HISTORY; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; RELAPSE; REMISSION; TEACHING ROUND; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREA NITROGEN BLOOD LEVEL;

ADAM PROTEINS; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; PLASMA EXCHANGE; PLASMA VOLUME; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84857174089     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07230711     Document Type: Article

References (40)

1. Booth KK, Terrell DR, Vesely SK, George JN: Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 86: 743-751, 2011
2. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA; Canadian Apheresis Study Group: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325: 393-397, 1991
3. Michael M, Elliott EJ, Craig JC, Ridley G, Hodson EM: Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: A systematic review of randomized controlled trials. Am J Kidney Dis 53: 259-272, 2009
4. George JN, Kremer Hovinga JA, Terrell DR, Vesely SK, Lämmle B: TheOklahomaThromboticThrombocytopenicPurpura-Hemolytic Uremic Syndrome Registry: The Swiss connection. Eur J Haematol 80: 277-286, 2008
5. Grys TE, Sloan LM, Rosenblatt JE, Patel R: Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from non-enriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. J Clin Microbiol 47: 2008-2012, 2009
6. Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B, Carey R, Crandall C, Hurd S, Kaplan R, Neill M, Shea S, Somsell P, Tobin-D'Angelo M, Griffin PM, Gerner-Smidt P: Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 58: 1-14, 2009
7. Brunskill SJ, Tusold A, Benjamin S, Stanworth SJ, Murphy MF: A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Transfus Med 17: 17-35, 2007
8. George JN, Vesely SK, Terrell DR: The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: A community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol 41: 60-67, 2004
9. Rock G, Kelton JG, Shumak KH, Buskard NA, Sutton DMC, Benny WB; Canadian Apheresis Group: Laboratory abnormalities in thrombotic thrombocytopenic purpura. Br J Haematol 103: 1031-1036, 1998
10. Vesely SK, Li X, McMinn JR, Terrell DR, George JN: Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 44: 1149-1158, 2004
11. Goodship THJ, Kavanagh D: Pulling the trigger in atypical he-molytic uremic syndrome: The role of pregnancy. J Am Soc Nephrol 21: 731-732, 2010
12. Martin JN, Bailey AP, Rehberg JF, Owens MT, Keiser SD, May WL: Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. Am J Obstet Gynecol 199: 98-104, 2008
13. Espinosa G, Bucciarelli S, Cervera R, Lozano M, Reverter J-C, de la Red G, Gil V, Ingelmo M, Font J, Asherson RA: Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63: 730-736, 2004
14. Swisher KK, Doan JT, Vesely SK, Kwaan HC, Kim B, Lämmle B, Kremer Hovinga JA, George JN: Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Report of five patients with a systematic review of published reports. Haematologica 92: 936-943, 2007
15. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN: Disseminated malignancy misdiagnosed as thrombotic throm-bocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist 12: 11-19, 2007
16. van den Born JH, van der Hoeven NV, Groot E, Lenting PJ, Meijers JCM, Levi M, van Montfrans GA: Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension 51: 862-866, 2008
17. Kojouri K, George JN: Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 19: 148-154, 2007
18. Park YA, Waldrum MR, Marques MB: Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults. Am J Clin Pathol 133: 460-465, 2010
19. Vesely SK, George JN, Lämmle B, Studt J-D, Alberio L, El-Harake MA, Raskob GE: ADAMTS13 activity in thrombotic thrombocy-topenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102: 60-68, 2003
20. Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M, Mikovic D, Karimi M, Giuffrida G, Laurenti L, Mannucci PM: ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 93: 232-239, 2008
21. Noris M, Remuzzi G: Atypical hemolytic-uremic syndrome. N Engl J Med 361: 1676-1687, 2009
22. Clark WF, Forzley BR, Sontrop JM, Kadri A, Moist LM, Suri RS, Salvadori MI, Garg AX: TTP/HUS: Observationalstudies generate hypotheses that lead to randomized controlled trials. Kidney Int Suppl 75[S112]: S50-S51, 2009
23. George JN: How I treat patients with thrombotic thrombocyto-penic purpura: 2010. Blood 116: 4060-4069, 2010
24. Forzley BR, Sontrop JM, Macnab JJ, Chen S, Clark WF: Treating TTP/HUS with plasma exchange: A single centre's 25-year experience. Br J Haematol 143: 100-106, 2008
25. Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ: Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol 136: 451-461, 2007
26. De la Rubia J, Moscardo F, Gomez MJ, Guardia R, Rodriguea P, Sebrango A, Zamora C, Deben G, Goterris R, Lopez R, Pena F, Pujol M, Vidaller A, del Rio-Garma J: Sanz MA on behalf of the Grupo Espanol de Aferesis (GEA): Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory throm-botic thrombocytopenic purpura: Results of a Spanish multi-center study. Transfus Apheresis Sci 43: 299-303, 2010
27. George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK: Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher 21: 49-56, 2006
28. Viswanathan S, Rovin BH, Shidham GB, Raman SV, Weinberg M, Patricia A, George JN, Wu HM, Cataland SR: Long-term, sub-clinical cardiacand renal complications inpatients with multiple relapsesof thrombotic thrombocytopenic purpura. Br J Haematol 149: 623-625, 2010
29. Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN: Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion 49: 118-124, 2009
30. Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF: Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression. JAMA 290: 1360-1370, 2003
31. Clark WF, Sontrop JM, Macnab JJ, Salvadori M, Moist L, Suri R, Garg AX: Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: A prospective cohort study. BMJ 341: c6020, 2010
32. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI: Relative nephroprotection during Escherichia coli O157:H7 infections: Association with intravenous volume expansion. Pediatrics 115: e673-e680, 2005
33. Lapeyraque A-L, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont M-J, Le Deist F, Niaudet P, Schaefer F: Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364: 2561-2563, 2011
34. Greinacher A, Friesecke S, Abel P, Dressel A, Stracke S, Fiene M, Ernst F, Selleng K, Weissenborn K, Schmidt BM, Schiffer M, Felix SB, Lerch MM, Kielstein JT, Mayerle J: Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemo-lytic uraemic syndrome: A prospective trial. Lancet 378: 1166-1173, 2011
35. Colic E, Dieperink H, Titlestad K, Tepel M: Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: An observational study. Lancet 378: 1089-1093, 2011
36. Allford SL, Hunt BJ, Rose P, Machin SJ; Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 120: 556-573, 2003
37. Cohen JA, Brecher ME, Bandarenko N: Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apher 13: 16-19, 1998
38. Haas M, Leko-Mohr Z, Lang T, Jansen M, Knöbl P, Hörl WH, Druml W: The LDH ratio as a marker for response to plasma exchange in HUS/TTP of the adult. Clin Nephrol 57: 414-420, 2002
39. Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN: Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion 49: 873-887, 2009
40. Shibagaki Y, Fujita T: Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP): Can we differentiate one from the other? Hypertens Res 28: 89-95, 2005